de la Fuente-Fernandez R - Search Results

1

Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function.

Troiano AR, Schulzer M, de la Fuente-Fernandez R, Mak E, McKenzie J, Sossi V, McCormick S, Ruth TJ, Stoessl AJ. Troiano AR, et al. Synapse. 2010 Feb;64(2):146-51. doi: 10.1002/syn.20708. Synapse. 2010. PMID: 19852071

2

Dopamine receptors in Parkinson's disease: imaging studies.

Stoessl AJ, de la Fuente-Fernández R. Stoessl AJ, et al. Adv Neurol. 2003;91:65-71. Adv Neurol. 2003. PMID: 12442664 Review. No abstract available.

3

Age and severity of nigrostriatal damage at onset of Parkinson's disease.

De La Fuente-Fernández R, Lim AS, Sossi V, Adam MJ, Ruth TJ, Calne DB, Stoessl AJ, Lee CS. De La Fuente-Fernández R, et al. Synapse. 2003 Feb;47(2):152-8. doi: 10.1002/syn.10160. Synapse. 2003. PMID: 12454953

4

VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.

De La Fuente-Fernández R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ. De La Fuente-Fernández R, et al. Synapse. 2003 Jul;49(1):20-8. doi: 10.1002/syn.10199. Synapse. 2003. PMID: 12710012

5

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.

de la Fuente-Fernández R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ. de la Fuente-Fernández R, et al. Brain. 2004 Dec;127(Pt 12):2747-54. doi: 10.1093/brain/awh290. Epub 2004 Aug 25. Brain. 2004. PMID: 15329355

6

Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.

Lee CS, Schulzer M, de la Fuente-Fernández R, Mak E, Kuramoto L, Sossi V, Ruth TJ, Calne DB, Stoessl AJ. Lee CS, et al. Arch Neurol. 2004 Dec;61(12):1920-5. doi: 10.1001/archneur.61.12.1920. Arch Neurol. 2004. PMID: 15596613

7

Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.

Koochesfahani KM, de la Fuente-Fernández R, Sossi V, Schulzer M, Yatham LN, Ruth TJ, Blinder S, Stoessl AJ. Koochesfahani KM, et al. Mov Disord. 2006 Jul;21(7):970-5. doi: 10.1002/mds.20857. Mov Disord. 2006. PMID: 16570297 Clinical Trial.

8

Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.

Sossi V, de la Fuente-Fernández R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ. Sossi V, et al. Ann Neurol. 2007 Nov;62(5):468-74. doi: 10.1002/ana.21204. Ann Neurol. 2007. PMID: 17886297

9

Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study.

Sossi V, Dinelle K, Topping GJ, Holden JE, Doudet D, Schulzer M, Ruth TJ, Stoessl AJ, de la Fuente-Fernandez R. Sossi V, et al. J Neurochem. 2009 Apr;109(1):85-92. doi: 10.1111/j.1471-4159.2009.05904.x. Epub 2009 Jan 22. J Neurochem. 2009. PMID: 19183257 Free article.

10

Visualizing vesicular dopamine dynamics in Parkinson's disease.

de la Fuente-Fernández R, Sossi V, McCormick S, Schulzer M, Ruth TJ, Stoessl AJ. de la Fuente-Fernández R, et al. Synapse. 2009 Aug;63(8):713-6. doi: 10.1002/syn.20653. Synapse. 2009. PMID: 19391152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters